Sigma Healthcare (ASX:SIG) said that growth in its normalized earnings before taxes and interest (EBIT) for the nine months to March 31 was broadly consistent with Chemist Warehouse Group's reported 36% increase in normalized EBIT in the fiscal first half, according to a Tuesday Australian bourse filing.
Chemist Warehouse Group's normalized EBIT for the first half of fiscal 2025 came in at AU$446.1 million, compared with the AU$328.4 million reported in the prior-year period.
The company said it incurred transaction costs of AU$42.4 million up to March 31, with AU$8.1 million incurred in the first half of fiscal 2025 and AU$34.3 million incurred in the third quarter.
Sigma Healthcare's shares fell almost 6% in recent Tuesday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.